Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

RecruitingOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Amyloid CardiomyopathyTransthyretin Amyloid CardiomyopathyTransthyretin Cardiac Amyloidosis
Interventions
OTHER

non interventional study

non interventional study

Trial Locations (1)

75018

RECRUITING

Bichat, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bichat Hospital

OTHER

collaborator

Bioquantis

UNKNOWN

lead

Algalarrondo Vincent

OTHER